FDA panel recommends Gilead’s Quad for HIV – Reuters

by Blogburger on May 11, 2012


CBC.ca
FDA panel recommends Gilead's Quad for HIV
Reuters
By David Morgan | WASHINGTON (Reuters) – A US Food and Drug Administration panel of outside experts on Friday recommended the use of Gilead Sciences Inc's Quad pill for untreated HIV patients. The FDA advisory committee voted 13-1 to endorse the
FDA reviews first rapid, take-home test for HIV The Associated Press
FDA Panel Backs Gilead's HIV 'Quad' MedicineWall Street Journal
HIV advocates say Truvada could save livesCBS News
MedPage Today -BusinessWeek
all 1,824 news articles »

Health – Google News

by Amazon Auto Links

Comments on this entry are closed.

Previous post:

Next post: